Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d] pyrimidines

Carbohydrate Research

Volumn 308, Issue 3-4, 1998, Pages 319-328

  Huang, Bao Guo ^a   Bobek, Miroslav ^a  

^a Roswell Cancer Institute   (United States)

Author keywords

3' Branched 3' deoxy nucleosides; Aminomethyl nucleosides; Antitumor activity; Pyrrolo 2,3 d pyrimidines; Synthesis

Indexed keywords

NUCLEOSIDE; PYRROLO[2,3 D]PYRIMIDINE DERIVATIVE; SANGIVAMYCIN DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYSTALLIZATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROGENATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PYRIMIDINE NUCLEOSIDES; TUMOR CELLS, CULTURED;

EID: 0032052951     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6215(98)00098-6     Document Type: Article

References (20)

1. M. Sharma, H. Wikiel, R. Hromchak, A. Bloch, and M. Bobek, Nucleosides Nucleotides, 12 (1993) 295-304.
2. M. Bobek and A. Bloch, Nucleosides Nucleotides, 13 (1994) 429-435.
3. P.D. Davis, L.H. Elliott, W. Harris, C.H. Hill, S.A. Hurst, E. Keech, M.K.H. Kumar, G. Lawton, J.S. Nixon, and S.E. Wilkinson, J. Med. Chem., 35 (1992) 994-1001.
4. T. Iimori, Y. Murai, Y. Wakizaka, Y. Ohtsuka, S. Ohuchi, Y. Kodama, and T. Oishi, Chem. Pharm. Bull., 41 (1993) 775-777.
5. M. Sharma, A. Bloch, and M. Bobek, Nucleosides Nucleotides, 12 (1993) 643-648.
6. H. Vorbrüggen, K. Krolikiewicz, and B. Bennua, Chem. Ber., 114 (1981) 1234-1255.
7. W. Meyer zu Reckendorf and U. Spohr, Liebigs Ann. Chem., (1982) 137-149.
8. A. Holý, Collect. Czech. Chem. Commun., 47 (1982) 2969-2988.
9. K. Kefurt, K. Capek, Z. Kefurtova, and J. Jary, Collect. Czech. Chem. Commun., 51 (1986) 391-400.
10. W.A. Szarek, A. Zamojski, K.N. Tiwari, and E.R. Ison, Tetrahedron Lett., 27 (1986) 3827-3830.
11. (a) G. Legler and S. Pohl, Carbohydr. Res., 155 (1986) 119-129;
12. (b) E.M. Acton, R.N. Goerner, H.S. Uh, K.J. Ryan, D.W. Henry, C.E. Cass, and G.A. LePage, J. Med. Chem., 22 (1979) 518-525.
13. A. Billich, U. Stockhorve, and H. Witzel, Nucleic Acids Res., 11 (1983) 7611-7624.
14. E.E. Swayze, J.M. Hinkley, and L.B. Townsend, in L.B. Townsend and R.S. Tipson (Eds.), Nucleic Acids Research, Part 4, Wiley-Interscience, New York, 1991, pp 16-18.
15. R.L. Tolman, R.K. Robins, and L.B. Towsend, J. Am. Chem. Soc., 91 (1969) 2102-2108.
16. M. Sharma, Y.X. Li, M. Ledvina, and M. Bobek, Nucleosides Nucleotides, 14 (1995) 1831-1852.
17. M. Karplus, J. Chem. Phys., 30 (1959) 11-15.
18. H. Vorbrüggen, Acc. Chem. Res., 28 (1995) 509-520.
19. R.J. Suhadolnik, in R.J. Suhadolnik (Ed.), Nucleoside Antibiotics, Vol. 1, Wiley-Interscience, New York, 1970, pp 298-353.
20. P.S. Ritch and R.I. Glaser, in R.I. Glaser (Ed.), Pyrrolo[2,3-d]pyrimidine Nucleosides. Developments and Cancer Chemotherapy, CRC Press, 1984, pp 1-33.